Joe Wiley
Founder bei AMRYT PHARMA PLC
Profil
Joseph A.
Wiley was the founder of Amryt Pharma Holdings Ltd.
(founded in 2015) and Amryt Pharma Plc (founded in 2019), where he held the titles of Chief Executive Officer & Executive Director (2016-2023) and Chief Executive Officer & Director (2019-present), respectively.
He currently holds the position of Chief Executive Officer at Amryt Pharmaceuticals DAC and is a Member of the Royal College of Physicians of Ireland.
Dr. Wiley's former positions include Chief Executive Officer of Enlarged Group, President & Director of Aegerion Pharmaceuticals, Inc., Investment Director at Aberdeen Asset Managers Private Equity (2005-2008), Investment Director at Synova Capital LLP (2010), Director-Medical at Astellas Pharma Co. Ltd.
(2010-2012), and Investment Manager at Inventages Venture Capital Investment, Inc. He also served as an Independent Member-Supervisory Board at Innocoll AG and as a Member-Supervisory Board at Innocoll Holdings Plc.
Dr. Wiley holds an MBA degree from INSEAD.
Aktive Positionen von Joe Wiley
| Unternehmen | Position | Beginn |
|---|---|---|
| AMRYT PHARMA PLC | Founder | 24.09.2019 |
Amryt Pharmaceuticals DAC
 Amryt Pharmaceuticals DAC Pharmaceuticals: MajorHealth Technology Amryt Pharmaceuticals DAC manufactures pharmaceutical products. The company was founded on August 19, 2015 and is headquartered in Ballsbridge, Ireland. | Chief Executive Officer | - |
| Royal College of Physicians of Ireland | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Joe Wiley
| Unternehmen | Position | Ende |
|---|---|---|
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Founder | 26.05.2023 |
Astellas Pharma Co. Ltd.
 Astellas Pharma Co. Ltd. Medical DistributorsDistribution Services Part of Astellas Pharma, Inc., Astellas Pharma Co. Ltd. is a company headquartered in Dublin, Ireland. The firm wholesales medical products. | Chief Tech/Sci/R&D Officer | 01.04.2012 |
Synova Capital LLP
 Synova Capital LLP Investment ManagersFinance Synova Capital LLP (Synova Capital) is a private equity firm founded in 2007 by Philip Simon Shapiro. The firm is headquartered in London. | Private Equity Investor | 01.08.2010 |
Aberdeen Asset Managers Private Equity
 Aberdeen Asset Managers Private Equity Investment ManagersFinance Aberdeen Asset Managers Private Equity (AAMPE) was founded in 1986 and is a private equity division of MCP-Maven Capital Partners UK LLP. MCP was established in 2009 through a management buyout from the Aberdeen-based Scottish investment management group AAM-Aberdeen Asset Management plc (LSE: ADN), which has offices worlwide. AAM remained a minority shareholder of MCP. AAMPE focuses on mid-market MBOs, MBIs, acquisition finance, replacement capital and development capital in the UK and abroad. They advise several segregated funds and operate out of offices throughout the UK. | Director of Investments | 31.08.2008 |
Inventages Venture Capital Investment, Inc
 Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture Capital Investment, Inc (Inventages Venture) is a venture capital firm founded in 2000 by Gunnar Carsten Weikert. The firm is headquartered in Nassau with an additional office in London. | Private Equity Investor | 06.03.2006 |
Ausbildung von Joe Wiley
| INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Aberdeen Asset Managers Private Equity
Aberdeen Asset Managers Private Equity Investment ManagersFinance Aberdeen Asset Managers Private Equity (AAMPE) was founded in 1986 and is a private equity division of MCP-Maven Capital Partners UK LLP. MCP was established in 2009 through a management buyout from the Aberdeen-based Scottish investment management group AAM-Aberdeen Asset Management plc (LSE: ADN), which has offices worlwide. AAM remained a minority shareholder of MCP. AAMPE focuses on mid-market MBOs, MBIs, acquisition finance, replacement capital and development capital in the UK and abroad. They advise several segregated funds and operate out of offices throughout the UK. | Finance |
Inventages Venture Capital Investment, Inc
Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture Capital Investment, Inc (Inventages Venture) is a venture capital firm founded in 2000 by Gunnar Carsten Weikert. The firm is headquartered in Nassau with an additional office in London. | Finance |
Synova Capital LLP
Synova Capital LLP Investment ManagersFinance Synova Capital LLP (Synova Capital) is a private equity firm founded in 2007 by Philip Simon Shapiro. The firm is headquartered in London. | Finance |
| Enlarged Group | |
Astellas Pharma Co. Ltd.
Astellas Pharma Co. Ltd. Medical DistributorsDistribution Services Part of Astellas Pharma, Inc., Astellas Pharma Co. Ltd. is a company headquartered in Dublin, Ireland. The firm wholesales medical products. | Distribution Services |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Innocoll Holdings Plc operates as a pharmaceutical company. It focuses on the development and commercialization of pharmaceutical technologies to meet healthcare challenges. The firm's late-stage product pipeline is focused on addressing patient needs for postsurgical pain management. The company was founded in 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Amryt Pharmaceuticals DAC
Amryt Pharmaceuticals DAC Pharmaceuticals: MajorHealth Technology Amryt Pharmaceuticals DAC manufactures pharmaceutical products. The company was founded on August 19, 2015 and is headquartered in Ballsbridge, Ireland. | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
